Old Web
English
Sign In
Acemap
>
Paper
>
First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α
First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α
2020
Amy D. Shapiro
Barbara A. Konkle
Stacy E. Croteau
Wolfgang Miesbach
Charles R. M. Hay
Rashid S. Kazmi
Marina Mihova
Savita Rangarajan
John Pasi
Keywords:
Clinical trial
first in human
Internal medicine
Medicine
Oncology
Cell therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]